Since the COVID-19 pandemic, pretty much everybody is familiar with this technology: paper-based rapid test strips, also called lateral flow immunoassays (LFIAs). They enable easy detection of biomarkers that indicate the presence of specific pathogens or states of health. Since the COVID-19 pandemic, pretty much everybody is familiar with this technology: paper-based rapid test strips, also called lateral flow immunoassays (LFIAs). They enable easy detection of biomarkers that indicate the presence of specific pathogens or states of health. Bio & Medicine Phys.org – latest science and technology news stories
Improving rapid tests: DNA nanotechnology boosts sensitivity of test strips
